Request that the FDA amend the prescription status of triptan medications to allow their availability as over-the-counter (OTC) products for the acute treatment of migraine headaches with or without aura in adults who have a previous diagnosis of migrainie
🏛 Food and Drug Administration (FDA)FDA-2026-P-0925
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.